Published in Diabetes on April 01, 1998
Detection of four diabetes specific autoantibodies in a single radioimmunoassay: an innovative high-throughput approach for autoimmune diabetes screening. Clin Exp Immunol (2011) 0.94
Elimination of dietary gluten and development of type 1 diabetes in high risk subjects. Rev Diabet Stud (2004) 0.80
Mapping of novel autoreactive epitopes of the diabetes-associated autoantigen IA-2. Clin Exp Immunol (2000) 0.77
Type 1 diabetes risk and autoantibody positivity in Sardinian migrants in the province of Pavia. N Am J Med Sci (2009) 0.76
Immune responses to glutamic acid decarboxylase and insulin in patients with gestational diabetes. Clin Exp Immunol (2004) 0.75
Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes (1999) 3.00
Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass. Diabetologia (2010) 2.65
Low status control, high effort at work and ischemic heart disease: prospective evidence from blue-collar men. Soc Sci Med (1990) 2.63
Frequent interspecific genetic exchange between commensal Neisseriae and Neisseria meningitidis. Mol Microbiol (2000) 2.52
No association of antibodies to glutamic acid decarboxylase and diabetic complications in patients with IDDM. Diabetes Care (1995) 2.14
Pattern of month of birth in diabetic and non-diabetic adults. Isr Med Assoc J (2002) 2.03
Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk. Diabetologia (2009) 2.00
A lipoprotein characterizing obstructive jaundice. I. Method for quantitative separation and identification of lipoproteins in jaundiced subjects. J Clin Invest (1969) 1.93
Spirometry reference values for women and men 65 to 85 years of age. Cardiovascular health study. Am Rev Respir Dis (1993) 1.87
The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels. Atherosclerosis (1986) 1.85
Systematic review: the association between obesity and hepatocellular carcinoma - epidemiological evidence. Aliment Pharmacol Ther (2010) 1.76
Simvastatin reduces graft vessel disease and mortality after heart transplantation: a four-year randomized trial. Circulation (1997) 1.70
hAG-2 and hAG-3, human homologues of genes involved in differentiation, are associated with oestrogen receptor-positive breast tumours and interact with metastasis gene C4.4a and dystroglycan. Br J Cancer (2003) 1.65
Serum Lp(a) concentrations are unaffected by treatment with the HMG-CoA reductase inhibitor Pravastatin: results of a 2-year investigation. Clin Chim Acta (1991) 1.47
The prevalence of HTLV-III/LAV antibodies among intravenous drug users attending treatment programs in California: a preliminary report. N Engl J Med (1986) 1.46
Antibodies to bovine serum albumin (BSA) in type 1 diabetes and other autoimmune disorders. Exp Clin Endocrinol Diabetes (1997) 1.43
Carbohydrate-deficient transferrin is not a useful marker for the detection of chronic alcohol abuse. Eur J Clin Invest (1998) 1.42
Chronic work stress is associated with atherogenic lipids and elevated fibrinogen in middle-aged men. J Intern Med (1997) 1.38
[Is the alcoholic really sober, does the applicant drink, can the pilot still fly? CDT test often fails in reliability!]. MMW Fortschr Med (2000) 1.37
Transmission ratio distortion at the INS-IGF2 VNTR. Nat Genet (1999) 1.34
The health effects of involuntary smoking. Am Rev Respir Dis (1983) 1.34
A simple specific method for precipitation of low density lipoproteins. J Lipid Res (1983) 1.33
Isolation, characterization, and uptake in human fibroblasts of an apo(a)-free lipoprotein obtained on reduction of lipoprotein(a). J Lipid Res (1985) 1.33
Early autoantibody responses in prediabetes are IgG1 dominated and suggest antigen-specific regulation. J Immunol (1999) 1.29
Concentration of insulin autoantibodies at onset of type I diabetes. Inverse log-linear correlation with age. Diabetes Care (1988) 1.27
Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions. J Lipid Res (2000) 1.25
Autoantibodies to IA-2beta improve diabetes risk assessment in high-risk relatives. Diabetologia (2008) 1.25
Development of celiac disease-associated antibodies in offspring of parents with type I diabetes. Diabetologia (2000) 1.23
Natural course of remission in IDDM during 1st yr after diagnosis. Diabetes Care (1992) 1.21
Breastfeeding habits in families with Type 1 diabetes. Diabet Med (2007) 1.20
Early development and spreading of autoantibodies to epitopes of IA-2 and their association with progression to type 1 diabetes. J Immunol (1998) 1.19
Nucleosomes in serum as a marker for cell death. Clin Chem Lab Med (2001) 1.17
No major association of breast-feeding, vaccinations, and childhood viral diseases with early islet autoimmunity in the German BABYDIAB Study. Diabetes Care (2000) 1.15
Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients. J Clin Invest (1997) 1.14
Nucleosomes in serum of patients with benign and malignant diseases. Int J Cancer (2001) 1.13
Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS). Eur J Clin Invest (1994) 1.12
Cellular immune response to diverse islet cell antigens in IDDM. Diabetes (1996) 1.11
Proposed guidelines on screening for risk of type 1 diabetes. Diabetes Care (2001) 1.11
Prediction of type 1 diabetes postpartum in patients with gestational diabetes mellitus by combined islet cell autoantibody screening: a prospective multicenter study. Diabetes (1997) 1.10
Comparison of a novel micro-assay for insulin autoantibodies with the conventional radiobinding assay. Diabetologia (1998) 1.10
Costs of hepatitis C. Arch Intern Med (2001) 1.10
A behavioral evaluation of pest control workers with short-term, low-level exposure to the organophosphate diazinon. Am J Ind Med (1987) 1.10
No evidence for an association of coxsackie virus infections during pregnancy and early childhood with development of islet autoantibodies in offspring of mothers or fathers with type 1 diabetes. J Autoimmun (2001) 1.09
Serum lipoprotein Lp(a) concentrations are not influenced by an HMG CoA reductase inhibitor. Klin Wochenschr (1988) 1.09
Characterization of insulin autoantibodies in relatives of patients with type I diabetes. Diabetes (1993) 1.09
Structural relationship of an apolipoprotein (a) phenotype (570 kDa) to plasminogen: homologous kringle domains are linked by carbohydrate-rich regions. Biol Chem Hoppe Seyler (1987) 1.08
Immunoglobulin G insulin autoantibodies in BABYDIAB offspring appear postnatally: sensitive early detection using a protein A/G-based radiobinding assay. J Clin Endocrinol Metab (1999) 1.08
Serum CEA and CA 15-3 as prognostic factors in primary breast cancer. Br J Cancer (2002) 1.08
Early signs of lung fibrosis after in vitro treatment of rat lung slices with CdCl2 and TGF-beta1. Histochem Cell Biol (2004) 1.07
Development of autoimmunity to transglutaminase C in children of patients with type 1 diabetes: relationship to islet autoantibodies and infant feeding. Diabetologia (2006) 1.07
BABYDIET, a feasibility study to prevent the appearance of islet autoantibodies in relatives of patients with Type 1 diabetes by delaying exposure to gluten. Diabetologia (2004) 1.05
A lipoprotein characterizing obstructive jaundice. II. Isolation and partial characterization of the protein moieties of low density lipoproteins. J Clin Invest (1970) 1.04
Incidence rates of fatal and nonfatal myocardial infarction in relation to the lipoprotein profile: first prospective results from the Göttingen Risk, Incidence, and Prevalence Study (GRIPS). Klin Wochenschr (1988) 1.04
Type 1 diabetes risk assessment: improvement by follow-up measurements in young islet autoantibody-positive relatives. Diabetologia (2006) 1.03
Early expression and high prevalence of islet autoantibodies for DR3/4 heterozygous and DR4/4 homozygous offspring of parents with Type I diabetes: the German BABYDIAB study. Diabetologia (1999) 1.03
Transforming growth factor-beta1 induces activation of Ras, Raf-1, MEK and MAPK in rat hepatic stellate cells. FEBS Lett (1997) 1.01
Enhanced procoagulatory activity (PCA) of human monocytes/macrophages after in vitro stimulation with chemically modified LDL. Atherosclerosis (1989) 1.01
Maturation of the humoral autoimmune response to epitopes of GAD in preclinical childhood type 1 diabetes. Diabetes (2000) 1.01
Hypertriglyceridaemia secondary to liver disease. Eur J Clin Invest (1974) 1.01
Improved haemorheology associated with a reduction in plasma fibrinogen and LDL in patients being treated by heparin-induced extracorporeal LDL precipitation (HELP). Eur J Clin Invest (1989) 1.00
Genetic association of zinc transporter 8 (ZnT8) autoantibodies in type 1 diabetes cases. Diabetologia (2012) 1.00
Circulating nucleosomes in serum. Ann N Y Acad Sci (2001) 0.99
Clinical relevance of the quantification of apolipoprotein E in cerebrospinal fluid. Clin Chim Acta (1991) 0.98
Psychological impact of childhood islet autoantibody testing in families participating in the BABYDIAB study. Diabet Med (2004) 0.98
Comparison of low molecular weight heparin to standard heparin in hemodialysis/hemofiltration. Kidney Int (1988) 0.97
Characteristics of rapid vs slow progression to type 1 diabetes in multiple islet autoantibody-positive children. Diabetologia (2013) 0.96
Apolipoprotein AIMarburg: studies on two kindreds with a mutant of human apolipoprotein AI. Hum Genet (1982) 0.96
Seven-year follow-up of workers exposed to 1,2-dibromo-3-chloropropane. J Occup Med (1986) 0.96
Heterogeneity of human lipoprotein Lp[a]: cytochemical and biochemical studies on the interaction of two Lp[a] species with the LDL receptor. J Lipid Res (1990) 0.96
Formation of lipoprotein-X. Its relationship to bile compounds. J Clin Invest (1976) 0.96
Changes of vitamin D3 serum concentrations at the onset of immune-mediated type 1 (insulin-dependent) diabetes mellitus. Diabetes Res (1991) 0.94
Apoptosis in serum of patients with solid tumours. Anticancer Res (1999) 0.94
Determination of LDL- and scavenger-receptor activity in adherent and non-adherent cultured cells with a new single-step fluorometric assay. Biochim Biophys Acta (1996) 0.94
Epidemiological evidence for work load as a risk factor for osteoarthritis of the hip: a systematic review. PLoS One (2012) 0.93
Alterations of apolipoprotein B metabolism in HIV-infected patients with antiretroviral combination therapy. J Acquir Immune Defic Syndr (2001) 0.93
Morphologic studies on adult neuronal-ceroid lipofuscinosis (NCL). Clin Neuropathol (1982) 0.93
Region-related risk factors for respiratory symptoms in European and Californian farmers. Eur Respir J (2003) 0.92
Sturucture of an abnormal plasma lipoprotein (LP-X) characterizing obstructive jaundice. Biochim Biophys Acta (1972) 0.92
Transforming growth factor-beta1-induced activation of the Raf-MEK-MAPK signaling pathway in rat lung fibroblasts via a PKC-dependent mechanism. Biochem Biophys Res Commun (1998) 0.92
Sensitive methods to study human apolipoprotein B metabolism using stable isotope-labeled amino acids. Am J Physiol (1996) 0.92
Prevalence, characteristics and diabetes risk associated with transient maternally acquired islet antibodies and persistent islet antibodies in offspring of parents with type 1 diabetes. J Clin Endocrinol Metab (2001) 0.92
Computed tomography in late-onset metachromatic leucodystrophy. Neuroradiology (1984) 0.92
Ten-year follow-up results from the Goettingen Risk, Incidence and Prevalence Study (GRIPS). I. Risk factors for myocardial infarction in a cohort of 5790 men. Atherosclerosis (1997) 0.92
Validity of screening for individuals at risk for type I diabetes by combined analysis of antibodies to recombinant proteins. Diabetes Care (1997) 0.92
Compound heterozygosity for a Wolman mutation is frequent among patients with cholesteryl ester storage disease. J Lipid Res (2000) 0.90
Whispering-gallery-mode-resonator-based ultranarrow linewidth external-cavity semiconductor laser. Opt Lett (2010) 0.90
Kerr frequency comb generation in overmoded resonators. Opt Express (2012) 0.90
Delay of type I diabetes in high risk, first degree relatives by parenteral antigen administration: the Schwabing Insulin Prophylaxis Pilot Trial. Diabetologia (1998) 0.89
Generation of near-infrared frequency combs from a MgF₂ whispering gallery mode resonator. Opt Lett (2011) 0.89
Induction of glomerulosclerosis by dietary lipids. A functional and morphologic study in the rat. Lab Invest (1989) 0.89
Fish oil feeding results in an enhancement of cholesterol-induced atherosclerosis in rabbits. Atherosclerosis (1987) 0.89
Selective removal of low density lipoproteins (LDL) by precipitation at low pH: first clinical application of the HELP system. Klin Wochenschr (1987) 0.89
Serum cholesterol and mortality in patients with multiple organ failure. Crit Care Med (2000) 0.89
Analytical performance of the random access analyser Hitachi 737. A multicentre evaluation. J Clin Chem Clin Biochem (1986) 0.88
High-dose intravenous insulin infusion versus intensive insulin treatment in newly diagnosed IDDM. Diabetes (1997) 0.88
Reduction of circulating cholesterol and apolipoprotein levels during sepsis. Clin Chem Lab Med (1999) 0.88
Early infant diet in children at high risk for type 1 diabetes. Horm Metab Res (2009) 0.88